The active ingredient that makes magic mushrooms so magic — the psychedelic drug psilocybin — is one step closer to becoming a legal treatment for difficult cases of depression. This week, the company Compass Pathways announced that it had received the Food and Drug Administration’s Breakthrough Therapy designation for its psilocybin-based…
Now you can get the top stories from Gizmodo delivered to your inbox. Enter your email below.
By subscribing you agree to our Terms of Use and Privacy Policy.